Earlier in the week, I wrote about a cancer vaccine treatment that Stanford pathologist Edgar Engleman, MD, developed in the early 90s. As expected, the FDA gave the vaccine, called Provenge, the thumbs up today; according to Dow Jones (subscription required), the agency approved Provenge for patients with advanced prostate cancer who have failed hormone therapy treatment.
Popular posts
How remdesivir works, and why it’s not the ultimate coronavirus killer
How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?
What to do if you test positive for COVID-19
From how to quarantine to how to monitor your oxygen levels, a Stanford physician offers tips on what to do if you have COVID-19.